AVID200 neutralizes TGF-beta1 and -beta3, the principal immunosuppressive TGF-beta isoforms overexpressed by tumours, and sensitizes tumours to immune checkpoint inhibitors
Gespeichert in:
Veröffentlicht in: | Annals of oncology 2019-10, Vol.30, p.v190 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | v190 |
container_title | Annals of oncology |
container_volume | 30 |
creator | Gruosso, T. O’Connor, M. Denis, J.-F. Figueredo, R. Koropatnick, J. Tremblay, G. Tikhomirov, I.A. |
description | |
doi_str_mv | 10.1093/annonc/mdz244.066 |
format | Article |
fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdz244_066</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_annonc_mdz244_066</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1336-3fd585effcf3fe25dd7c2c711aaefae5e2f8685d02cb10dc074549880a7eb48d3</originalsourceid><addsrcrecordid>eNo9kM1OAjEQx3vQREQfwFsfgIV-7OeRoCAJiRf0uum201Bl203bJcIz-ZDiQjzNZPKf32R-CD1RMqWk4jNhrbNy1qoTS9MpyfMbNCIV40mR8fQO3YfwSQjJK1aN0M_8Y_3MCMEW-ujF3pwg4O1qmTQQBcXCKjy0fILjDnDnjZWmE3ts2ra3LvRd5yEEc4D_LWyC0863AbsDePgeAqBwc8Sxb13vw2TgBrDBxOHgdY6ju3AByx3Ir84ZG7GxO9OY6Hx4QLda7AM8XusYvS9ftovXZPO2Wi_mm0RSzvOEa5WVGWgtNdfAMqUKyWRBqRCgBWTAdJmXmSJMNpQoSYo0S6uyJKKAJi0VHyN64UrvQvCg6_PfrfDHmpL6T3F9UVxfFNdnxfwXCKJ5cA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>AVID200 neutralizes TGF-beta1 and -beta3, the principal immunosuppressive TGF-beta isoforms overexpressed by tumours, and sensitizes tumours to immune checkpoint inhibitors</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Gruosso, T. ; O’Connor, M. ; Denis, J.-F. ; Figueredo, R. ; Koropatnick, J. ; Tremblay, G. ; Tikhomirov, I.A.</creator><creatorcontrib>Gruosso, T. ; O’Connor, M. ; Denis, J.-F. ; Figueredo, R. ; Koropatnick, J. ; Tremblay, G. ; Tikhomirov, I.A.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>DOI: 10.1093/annonc/mdz244.066</identifier><language>eng</language><ispartof>Annals of oncology, 2019-10, Vol.30, p.v190</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1336-3fd585effcf3fe25dd7c2c711aaefae5e2f8685d02cb10dc074549880a7eb48d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Gruosso, T.</creatorcontrib><creatorcontrib>O’Connor, M.</creatorcontrib><creatorcontrib>Denis, J.-F.</creatorcontrib><creatorcontrib>Figueredo, R.</creatorcontrib><creatorcontrib>Koropatnick, J.</creatorcontrib><creatorcontrib>Tremblay, G.</creatorcontrib><creatorcontrib>Tikhomirov, I.A.</creatorcontrib><title>AVID200 neutralizes TGF-beta1 and -beta3, the principal immunosuppressive TGF-beta isoforms overexpressed by tumours, and sensitizes tumours to immune checkpoint inhibitors</title><title>Annals of oncology</title><issn>0923-7534</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNo9kM1OAjEQx3vQREQfwFsfgIV-7OeRoCAJiRf0uum201Bl203bJcIz-ZDiQjzNZPKf32R-CD1RMqWk4jNhrbNy1qoTS9MpyfMbNCIV40mR8fQO3YfwSQjJK1aN0M_8Y_3MCMEW-ujF3pwg4O1qmTQQBcXCKjy0fILjDnDnjZWmE3ts2ra3LvRd5yEEc4D_LWyC0863AbsDePgeAqBwc8Sxb13vw2TgBrDBxOHgdY6ju3AByx3Ir84ZG7GxO9OY6Hx4QLda7AM8XusYvS9ftovXZPO2Wi_mm0RSzvOEa5WVGWgtNdfAMqUKyWRBqRCgBWTAdJmXmSJMNpQoSYo0S6uyJKKAJi0VHyN64UrvQvCg6_PfrfDHmpL6T3F9UVxfFNdnxfwXCKJ5cA</recordid><startdate>201910</startdate><enddate>201910</enddate><creator>Gruosso, T.</creator><creator>O’Connor, M.</creator><creator>Denis, J.-F.</creator><creator>Figueredo, R.</creator><creator>Koropatnick, J.</creator><creator>Tremblay, G.</creator><creator>Tikhomirov, I.A.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201910</creationdate><title>AVID200 neutralizes TGF-beta1 and -beta3, the principal immunosuppressive TGF-beta isoforms overexpressed by tumours, and sensitizes tumours to immune checkpoint inhibitors</title><author>Gruosso, T. ; O’Connor, M. ; Denis, J.-F. ; Figueredo, R. ; Koropatnick, J. ; Tremblay, G. ; Tikhomirov, I.A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1336-3fd585effcf3fe25dd7c2c711aaefae5e2f8685d02cb10dc074549880a7eb48d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gruosso, T.</creatorcontrib><creatorcontrib>O’Connor, M.</creatorcontrib><creatorcontrib>Denis, J.-F.</creatorcontrib><creatorcontrib>Figueredo, R.</creatorcontrib><creatorcontrib>Koropatnick, J.</creatorcontrib><creatorcontrib>Tremblay, G.</creatorcontrib><creatorcontrib>Tikhomirov, I.A.</creatorcontrib><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gruosso, T.</au><au>O’Connor, M.</au><au>Denis, J.-F.</au><au>Figueredo, R.</au><au>Koropatnick, J.</au><au>Tremblay, G.</au><au>Tikhomirov, I.A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>AVID200 neutralizes TGF-beta1 and -beta3, the principal immunosuppressive TGF-beta isoforms overexpressed by tumours, and sensitizes tumours to immune checkpoint inhibitors</atitle><jtitle>Annals of oncology</jtitle><date>2019-10</date><risdate>2019</risdate><volume>30</volume><spage>v190</spage><pages>v190-</pages><issn>0923-7534</issn><doi>10.1093/annonc/mdz244.066</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0923-7534 |
ispartof | Annals of oncology, 2019-10, Vol.30, p.v190 |
issn | 0923-7534 |
language | eng |
recordid | cdi_crossref_primary_10_1093_annonc_mdz244_066 |
source | EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
title | AVID200 neutralizes TGF-beta1 and -beta3, the principal immunosuppressive TGF-beta isoforms overexpressed by tumours, and sensitizes tumours to immune checkpoint inhibitors |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T21%3A53%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=AVID200%20neutralizes%20TGF-beta1%20and%20-beta3,%20the%20principal%20immunosuppressive%20TGF-beta%20isoforms%20overexpressed%20by%20tumours,%20and%20sensitizes%20tumours%20to%20immune%20checkpoint%20inhibitors&rft.jtitle=Annals%20of%20oncology&rft.au=Gruosso,%20T.&rft.date=2019-10&rft.volume=30&rft.spage=v190&rft.pages=v190-&rft.issn=0923-7534&rft_id=info:doi/10.1093/annonc/mdz244.066&rft_dat=%3Ccrossref%3E10_1093_annonc_mdz244_066%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |